India's Drug Regulator Acknowledges Pharmaceutical Manufacturing Lapses Following Fatal Cough Syrup Incidents

Oct 09, 2025 12:51 am CST

India's top drug regulator has admitted serious deficiencies in pharmaceutical manufacturing practices after children died from suspected contaminated cough syrups. CDSCO investigations revealed manufacturers failing to test raw materials and finished products as required by law, leading to stricter enforcement measures nationwide. The scandal has damaged India's reputation as a global pharmaceutical supplier, with multiple states implementing emergency restrictions on cough medication distribution.